bf/NASDAQ:REGN_icon.jpeg

NASDAQ:REGN

Regeneron Pharmaceuticals, Inc.

  • Stock

USD

Last Close

646.87

06/11 22:07

Market Cap

116.07B

Beta: 0.23

Volume Today

1.11M

Avg: 576.83K

PE Ratio

25.31

PFCF: 33.11

    Description

    Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein oc...Show More

    Earnings

    Earnings per Share (Estimate*)

    5101520252017-08-032019-08-062021-08-052023-08-032025-02-07

    Revenue (Estimate*)

    1B2B3B4B5B2017-08-032019-08-062021-08-052023-08-032025-02-07

    *Estimate based on analyst consensus